Abstract
While Parkinson disease (PD) was for many years regarded as a textbook example of a nongenetic disease, this view has dramatically changed over the past 2 decades with the identification of a number of genes, mutations in which cause monogenic PD. In recent years, the identification of disease genes was facilitated due to the advent of next-generation sequencing (NGS) resulting in an exponential increase in the number of reported disease genes. 1 These observations require independent confirmation since the number of false-positive results has likewise considerably increased. 2
| Original language | English |
|---|---|
| Journal | Neurology |
| Volume | 86 |
| Issue number | 6 |
| Pages (from-to) | 577-579 |
| Number of pages | 3 |
| ISSN | 0028-3878 |
| DOIs | |
| Publication status | Published - 09.02.2016 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
-
SDG 10 Reduced Inequalities
Research Areas and Centers
- Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)
Fingerprint
Dive into the research topics of 'A nonsense mutation in CHCHD2 in a patient with Parkinson disease'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver